Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aubagio Concentration in Serum and CSF in MS
NCT04129736Phase 4Completed
- Start
- Oct 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of teriflunomide in multiple sclerosis (MS). Started Oct 2019; status: completed.
02
Drugs
teriflunomide
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04129736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04129736.